Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by...
NextPlat Corp (NASDAQ:NXPL, NXPLW)), NXPLW) ("NextPlat" or the "Company"), a global consumer products and servi...
OPKO Health, Inc. (NASDAQ:OPK) and Entera Bio Ltd. (NASDAQ:ENTX) ("Entera") today announced that new pharmacologic and ...
Will provide expertise across ModeX's portfolio of next generation multispecific antibodies for complex diseases involving ...
Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and maintains $2.25 price t...
OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.07) ...
